Blog Archives

Swissmedic erteilt Zulassung für Celtura

15. November 2009 – Das Schweizerische Heilmittelinstitut Swissmedic hat am 13. November 2009 den  Impfstoff Celtura  gegen die Schweinegrippe A(H1N1) zugelassen. Mit der Zulassung durch Swissmedic stehen somit in der Schweiz jetzt drei Impfstoffe gegen die A(H1N1)-Grippe zur Verfügung.

Im Unterschied zu den bereits im Oktober zugelassenen Impfstoffen Focetria und Pandemrix wird die Antigenkomponente von Celtura nicht auf der Basis von Hühnereiern sondern auf der Basis einer Zellkultur hergestellt.

Read more ›

Tags: , , ,

Swissmedic erteilt Zulassung für Pandemie-Impfstoffe

7. November, 2009 – Gemäss  einer Mitteilung vom 30. Oktober 2009  hat das Schweizerische Heilmittelinstitut Swissmedic hat am 23. und 27. Oktober zwei Impfstoffe gegen die Schweinegrippe A(H1N1) zugelassen. Es handelt sich hierbei zum einen um den Impfstoff Pandemrix A(H1N1), zum anderen um  den Impfstoff Focetria. Mit dieser Zulassung durch Swissmedic stehen in der Schweiz momentan zwei Impfstoffe gegen die A(H1N1)-Grippe zur Verfügung.

Read more ›

Tags: , , , , , , , , ,

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • Scientists find link between genes and ability to exercise February 26, 2020
    A team of researchers have discovered a genetic mutation that reduces a patient's ability to exercise efficiently.
  • ALS mystery illuminated by blue light February 26, 2020
    A joint research group in Japan has succeeded in reproducing key ALS symptoms in a small tropical fish by remotely controlling a disease-associated protein molecule using light illumination.
  • Researchers identify novel anti-aging targets February 26, 2020
    A recent study published in Nature has reported two conserved epigenetic regulators as novel anti-aging targets. The research, by scientists from Dr. Cai Shiqing's Lab at the Center for Excellence in Brain Science and Intelligence Technology, Institute of Neuroscience of the Chinese Academy of Sciences (CAS), and Dr. Jiang Lubing's team at Institut Pasteur, Shanghai […]
  • KAT6A syndrome: advances on the genetic bases and clinical picture of a rare disease February 26, 2020
    A research team has described five new cases of a rare disease known as KAT6A syndrome, of which there are only 80 dominant cases worldwide. This neurological and developmental disorder, caused by alterations in the lysine acetyltransferase 6A gene (KAT6A), involves intellectual disability, language impairment, low muscle tone, cardiovascular malformation and eye defects, among other […]
  • Researchers outline centralized genetic testing model February 26, 2020
    The Roberts Individualized Medical Genetics Center (RIMGC) at Children's Hospital of Philadelphia (CHOP) launched in 2014 as a first-of-its-kind system to help families navigate the complex process of genetic and genomic testing and standardize how genetic testing is performed across different clinical disciplines.